PET Pharmacokinetics Course 2021
19-23 July, Virtual PET PK Course 2021
PET Pharmacokinetics Course is designed for anyone who would like to gain a better understanding of the principles involved in PET kinetic modeling and analysis.
The course is immersive, including more than 15 lectures and interactive discussions.
Welcome to attend the digital event in July.
Course Faculty, PET PK 2021
Photo: 2021 PET PK digital course
PET PK in the Covid world
The PET Pharmacokinetics Course has been an annual event held immediately prior to NRM and Brain-PET for more than 20 years. Due to the still ongoing pandemic, we have decided to make 2021 our first digital event.
This will be a condensed version of the regular 3 day course.
- The number of places is limited to 78 particpants, and will be filled on a first come – first served basis.
- Each day will consist of three lectures followed by 30 min discussions in small groups with one of the tutors.
- To accommodate for as many people as possible around the world, the course will run for two hours per day between 17:00 and 19:00 CEST (Central European summer time)
(London 16:00-18:00, New York 11 am – 1 pm, Los Angeles 8-10 am, Beijing 11 pm – 1 am, Tokyo 12 pm – 2 am). - Time zone converter, for example: https://www.timeanddate.com/time/zone/sweden
Target group
The course is appropriate for physicians, researchers with a wide range of backgrounds, including medicine, physics, chemistry, neuroscience, and pharmacology as well as for graduate students. Course students have come from academia and industry.
Course Faculty 2021
- Olivier Barret (MIRCen, CEA, France)
- Ronald Boellaard (Amsterdam University Medical Centers, Netherlands)
- Richard Carson (Yale University, USA)
- Roger Gunn (Imperial College London, UK)
- Robert Koeppe (University of Michigan, USA)
- Adriaan Lammertsma, University Medical Centre Groningen, Netherlands
- Mark Lubberink (Uppsala University, Sweden)
- Gitte Moos Knudsen (Copenhagen University Hospital, Denmark)
- Marc Normandin (Harvard Medical School, USA)
- Julie Price (Martinos Center, Massachusetts General Hospital, Harvard University, USA)
- Mark Slifstein (Stony Brook University, USA)
- Joerg van den Hoff (Helmholtz-Zentrum Dresden-Rossendorf, Germany)
- Paolo Zanotti Fregonara (Molecular Imaging Branche, NIMH, USA)